ORDER GRANTING DEFENDANTS’ MOTION TO DISMISS
On May 22, 2014, ScripsAmerica, Inc. (“Scrips”) filed this action against Iron-ridge Global LLC d/b/a Ironridge Global IV, Ltd., John Kirkland, and Brendan O’Neil (collectively “Ironridge”), as well as certain fictitious defendants.
Ori June 25, 2014, defendants filed a motion to dismiss Scrips’ breach of contract, tortious bad faith, and declaratory relief claims under the Rooker-Feldman doctrine
On April 27, 2015, Scrips filed a second amended complaint.
I. FACTUAL BACKGROUND
This action concerns an allegedly fraudulent scheme devised by Ironridge. Scrips is a pharmaceuticals' distributor whose stock is publicly traded on the over-the-counter (“OTC”) market. The purported scheme arose from an agreement pursuant to which Scrips agreed to issue shares of its common stock to Ironridge in exchange for Ironridge’s undertaking to pay Scrips’ outstanding accounts payable.
During the calls, Ironridge requested that the contract memorializing the transaction include a provision for an adjustment to protect it in the event of a decline in Scrips’ stock price.
On October 4, 2013, Schneiderman, Kirkland, and O’Neil purportedly discussed the potential effect Ironridge’s sale of the stock it received might have on Scrips’ share price. Unlike other entities that had funded Scrips in exchange for stock, Ironridge allegedly represented that it would not act to manipulate or otherwise affect Scrips’ stock price.
Because the shares were unregistered, Ironridge and Scrips had to obtain court approval under California and federal securities laws before a transfer of the stock could take place.
The stipulation provided that if at any point during the calculation period the shares issued to Ironridge dropped below “any reasonably possible [f]inal [a]mount,” or if Scrips shares closed below 80% of the closing price on the trading day prior to entry of an order on the stipulation, Iron-ridge was entitled to request the issuance of additional shares.
On November 8, 2018, the parties filed a joint ex parte application in state court for an order approving the stipulation; they argued that ex parte relief was .necessary because the stipulation addressed the issuance of “shares of [Scrips] stock with a substantially fluctuating market price.”
■ On November 8, 2013, Superior Court Judge Rolf M. Treu entered an order' on the parties’ stipulation.
Bid whacking is purportedly a technique in which stock is sold at the bid price rather than a higher price as would “ordinarily” occur in trading.
Scrips contends that Ironridge acted with scienter, citing a larger pattern of similar fraud. It contends that the watchdog website “Scam Informer” recently observed that “[t]he destruction in stocks [of companies with which Ironridge] has completed transactions ... makes the devastation from Hurricane Irene seem tame by comparison.”
Based on the decline in Scrips’ share price, Ironridge filed an ex parte application in state court for an order compelling the issuance of additional shares under the May 6, 2014 stipulation.
On May 6, 2014, Judge Treu implicitly rejected each of Scrips’ arguments. He entered an order enforcing the order that had approved the stipulation (“enforcement order”), and directing that Scrips issue an additional 1,646,008 shares of common stock to Ironridge pursuant to the adjustment mechanism set forth in the stipulation.
On May 22, 2014, eight days after appealing the enforcement order, Scrips filed this action, alleging claims for breach of contract, tortious bad faith, violation of Rule 10b-5, and declaratory relief. Scrips sought compensatory and punitive damages, and a declaration that it need not issue the additional 1,646,008 shares that the Superior Court has ordered it to issue.
On June 30, 2015, the California Court of Appeal dismissed Scrips’ appeal of the state court enforcement order under the disentitlement doctrine.
A. Requests for Judicial Notice
1. Ironridge’s Request
Ironridge asks that the court take judicial notice of various documents that have been publicly filed with'the Securities & Exchange Commission (“SEC”).
In addition, the court can consider matters that- are proper subjects of judicial notice under Rule 201 of the Federal Rules of Evidence. Id. at 688-89; Branch v. Tunnell,
Ironridge asks that the court take judicial notice of Exhibits V through EE to its motion to dismiss the second amended complaint.
“Courts can consider securities offerings and corporate disclosure documents that are publicly available.” See Oklahoma Firefighters Pension & Ret. Sys. v. IXIA,
Exhibit CC is a public press release. Taking judicial notice of news reports and press releases is appropriate to show “that the market was aware of the information contained in news articles.” Heliotrope Gen., Inc. v. Ford Motor Co.,
With regard to Exhibit DD, Ironridge seeks judicial notice of a graph detailing Scrips’ stock price .fluctuations between September 2013 and May 2015,
= The parties’ state court stipulation and term sheet, which are Exhibits B and K to Ironridge’s request for judicial notice, are attached to the complaint and are properly considered in deciding the motion for that reason. See Lee,
2. Scrips’ Request
Scrips asks the court to take judicial notice of a June 23, 2014, SEC order instituting administrative cease and desist proceedings against Ironridge under Sections 15(b) and 21(c) of the Securities Exchange Act of 1934.
B. Legal Standard Governing Motions to Dismiss under Rule 12(b)(6)
A Rule 12(b)(6) motion tests the legal sufficiency of the claims asserted in the complaint. A Rule 12(b)(6) dismissal is proper only where there is either a “lack of a cognizable legal theory,” or “the absence of sufficient facts alleged under a
The court need not, however, accept as true unreasonable inferences or conclusory legal allegations cast in the form of factual allegations. See Bell Atlantic Corp. v. Twombly,
C. Whether the Court Should Dismiss Scrips’ Rule 10b-5 Claim
Ironridge argues that Scrips’ second amended Rule 10b-5 claim fails to cure the pleading deficiencies that the court identified in its first amended complaint. First, it contends that Scrips has fañed to plead an actionable misrepresentation or omission. Second, it asserts that Scrips has failed to allege manipulative conduct. Third, it argues that Scrips cannot plead reliance as a matter of law. Fourth, it contends that Scrips has failed adequately to allege facts giving rise to a strong inference of scienter. Ironridge asserts that, given Scrips’ multiple, unsuccessful attempts to plead a viable Rule 10b-5 claim, the claim should be dismissed with prejudice. The court addresses each argument in turn.'
1. Legal Standard Governing the Pleading of Securities Fraud Claims
“A securities fraud complaint under § 10(b) and Rule 10b-5 must satisfy the dual pleading requisites of Federal Rule of Civil Procedure 9(b) and the [Private Securities Litigation Reform Act (‘PSLRA’), 15 U.S.C. §. 78u-4].” In re VeriFone Holdings, Inc. Sec. Litig.,
Thus, a securities. fraud plaintiff cannot survive a motion to dismiss merely by alleging that certain statements were false. Metzler Inv. GMBH,
In 1995, Congress passed the PSLRA, which amended the Securities Exchange Act of 1934. The PSLRA modified Rule 9(b)’s particularity requirement, “providing that a securities fraud complaint [must] identify: (1) each statement alleged to have been misleading;' (2) the reason or reasons why the statement is misleading; and (3) all facts on which that belief is formed.” 15 U.S.C. § 78u-4(b)(1); see In re Silicon Graphics Inc. Securities Litigation,
In enacting the PSLRA, “Congress 'impose[d] heightened pleading requirements in actions brought pursuant to § 10(b) and Rule 10b-5.’” Tellabs,
2. Legal Standard Governing Liability Under Section 10(b) and Rule 10b-5
Rule 10b-5, promulgated by the Securities and Exchange Commission pursuant
“Regardless of whether a § 10(b) plaintiff alleges a misrepresentation,-omission, or manipulation, he.must plead and prove the following elements: (1) ... use or employfment of] a[] manipulative or deceptive device or contrivance; (2) scienter, i.e.[,] [a] wrongful state of mind; (3) a connection with the purchase or sale of a security; (4) reliance, often referred to ... as transaction causation; (5) economic loss; and (6) loss causation, i.e.[,] a causal connection between the manipulative or deceptive device or contrivance and the loss.” Desai v. Deutsche Bank Secs. Ltd.,
In addition to pleading falsity adequately, the pleading must “state with particularity facts giving rise to a strong inference that the defendant aeted with the required state of mind.” 15 U.S.C. §§ 78u-4(b)(2), “Scienter” refers to “a mental state embracing intent to deceive, manipulate, or defraud.” Ernst & Ernst v. Hochfelder,
The Ninth Circuit has emphasized that, to allege scienter, “plaintiffs ‘must plead, in great detail, facts that constitute strong circumstantial evidence of deliberately-reckless or conscious misconduct.’ ” Middlesex Retirement System v. Quest Software Inc., 527 F.Supp.2d 1164, 1179 (C.D.Cal.2007) (quoting Silicon Graphics,
“To qualify as ‘strong' within the intendment of ... the PSLRA ... an inference of scienter must be more than merely plausible or reasonable — it must be cogent and at least as compelling as any opposing inference of nonfraudulent intent.” Tellabs,
In determining whether a plaintiff has alleged facts giving rise to a strong inference of scienter, the court must draw all reasonable inferences from the allegations presented, including inferences unfavorable to plaintiff. Gompper v. VISX, Inc.,
The Ninth Circuit often treats the falsity and scienter analyses as “a single inquiry, because falsity and scienter are generally inferred from the same set of facts.” In re New Century,
3. Whether Scrips Has Pled Manipulative Conduct
To state a claim for market manipulation, Scrips must plead that Iron-ridge engaged in trading practices “intended to mislead investors by artificially affecting market activity.” Santa Fe Indus., Inc. v. Green,
In its prior order, the court held that Scrips’ first amended complaint did not sufficiently plead manipulative conduct because Scrips failed plausibly to allege any particular course of conduct that would amount to market manipulation. Scrips attempts to cure this deficiency in the second amended complaint by adding additional “bid whacking” allegations and by appending details concerning Scrips’ trading patterns to the complaint. It also makes many of the same arguments that the court previously found unavailing. The court addresses each in turn.
a. Use of Multiple Brokerage Firms
As the court noted, in its order dismissing this claim in the first amended complaint,. Scrips’ allegations that Iron-ridge’s use of multiple brokerage apcounts demonstrates market manipulation fail because many traders, especially institutional traders, use multiple accounts to place orders.
More fundamentally, the court noted that Scrips could not argue that the use of multiple brokerage- accounts constituted manipulation because it had to have been aware that Ironbridge was using multiple brokerage accounts. See Gurary v. Winehouse,
b. Ironridge’s Section 13(d) Disclosure Statement
Scrips next contends, as it did in the first amended complaint, that Ironridge’s
“IV received an initial issuance of 8,690,-000 ■ common shares, and may be required to return or be entitled, to receive shares, based on the calculation summarized in the prior paragraph. Based, on the $0.1820 per share closing price on November 7, 2013, IV would, be entitled to 5,650,000 shares. For purposes - of calculating the percent of class, the reporting persons have assumed-that there were 78,238,653 shares of common .stock outstanding immediately prior to the issuance of shares to IV, such that 5,650,-000 shares issued to IV would represent approximately 6.8% of the outstanding common stock -after such issuance.”-85 When the whole statement is considered,
it is clear that Ironridge' did not represent it' had received only 5,650,000 shares;' it clearly stated that it had received 8,690,-000 shares, but might' be required to return some of the shares because, based on the current trading price, it was entitled to only 5,650,000 shares. The court can’ discern nothing false of misleading about the statement; " hence it does not support Scrips’ market manipulation claim!
In addition, “the purpose of section 13(d) is to alert the marketplace to every large, rapid aggregation or accumulation of securities, regardless of [the] technique employed, which might represent a potential shift in corporate control.” GAF Corp. v. Milstein,
Finally, as noted, “a private plaintiff in ... a case [like this] must establish that he or she engaged in a securities trade in ignorance of the fact that the price was affected by the alleged manipulation.” Gurary,
c. “Bid Whacking”
In the .first amended complaint, Scrips alleged that Ironridge engaged in “marking the close” transactions and “bid whacking.” The second amended complaint omits any reference to “marking the close” transactions, and instead includes additional allegations concerning “bid whacking.” As the court stated in its order dismissing the first amended complaint, there are no reported decisions discussing “bid whacking,” let alone holding that it amounts to manipulative conduct. No secondary legal authority describes bid whacking or suggests that it should be considered manipulative.
“‘Bid whacking’ is accomplished when the selling party offers to sell their shares ‘at the bid’ instead of a higher price — this has the effect of lowering bids further and if the selling parties continue to reduce their demanded price (agree to sell again at the lower bid price), this will have the effect of lowering the overall share price for the day and often into at least the next trading day. If a selling party continues this day after trading day, the share price will start dropping due to this manipulation as well as panic in what were previously ‘long' holding stock holders; who now lose confidence in the stock and sell out their positions. If they are successful, and/or if other ‘funders’ are in the stock also selling, their model is, to consistently ‘bid whack’ the stock in an effort to ‘entice’ others to sell, causing the decline in price to the point where .they would be able to request more stock.”88
The Second Circuit has held that manipulation claims, while subject to Rule 9(b), often involve facts solely within the defendant’s knowledge; thus, “at the early stages of litigation, the plaintiff need not plead manipulation to the same degree of specificity as a plain misrepresentation claim.” ATSI II,
In its second amended complaint, Scrips attempts to bolsters its bid whacking allegations by pleading that Ironridge engaged in bid whacking between December 2013 and January 2014. Scrips corn, tends this ultimately drove “the price of [its] stock from seventeen cents to ten cents” over this five-month period.
Appending 200 pages of trading data, without identifying a single transaction as manipulative, along with vague testimony from an unnamed expert that Iron-ridge sold shares “at the lows of each trading day” over a two month period does not suffice. As Ironridge argues in its motion, “[a]mbiguous raw data by itself does not mean anything. ' It was Scrips’ burden to identify, out of the 200 pages, what trades were purportedly manipulative, ... why they were manipulative,
In any event, the court’s review of the transaction data for December 2013 and January 2014, the months Scrips contends are the most indicative of Ironridge’s purported misconduct, confirms that Ironridge sold its Scrips shares within the range at which all Scrips’ shares were sold. For example, on December 6, 2013, Scrips stock traded between $0.17 — $0.1956 a share; the price range at which Ironridge allegedly traded was $0.17 — $0.19.
Even on the days where Ironridge sold Scrips’ shares at or near intraday lows, the data indicate that other traders were selling Scrips shares at or near the same price. On December 9, 2013, for example, Scrips shares opened at $0.175 before a series of sales by traders other than Iron-
Further eroding Scrips’ theory is the fact Ironridge did not sell any shares on December 16, 2013. Despite that fact, Scrips shares opened at $0.14 and closed at $0.13 following an intraday low of $0,122; this is a trading range that is substantially similar to the range at which the stock traded on days Scrips contends Ironridge was manipulating, its stock.
Because Scrips fails to allege with particularity any specific conduct that constitutes market manipulation, its Rule 10b-5 claim must be dismissed to the extent it is based on such manipulation.
4. Whether Scrips Has Pled a Misrepresentation or Omission
■ Ironridge next argues that Scrips has again failed adequately to allege a misrepresentation or omission, as it has added no new allegations curing the deficiencies identified in the court’s order dismissing the first amended complaint.
a. The Adjustment Mechanism
Scrips alleges that the adjustment mechanism set forth in the parties’ agreement and stipulation is “incredibly convoluted and virtually unintelligible.”
In addition to signing the stipulation, moreover, Scrips joined Ironridge in filing an ex parte application seeking approval of the stipulated judgment.
b. Use of Multiple Brokerage Accounts
The court previously dismissed Scrips’ omission allegations to the extent they were based on Ironridge’s failure to disclose the use of multiple brokerage accounts. “Under Rule 10b-5(b), a defendant can be liable for the omission of material information if he or she has a duty to disclose that information.” WPP Luxembourg Gamma Three Sarl v. Spot Runner, Inc.,
Furthermore, and perhaps most importantly, as noted, Scrips knew the specific brokerage houses to which it delivered shares under the agreement because its transfer agent delivered the shares.
For both reasons, therefore, Scrips has not adequately alleged a misrepresentation
c.: Promise Not to Engage in Manipulative Conduct
Scrips also alleges that Ironridge falsely promised that it would not engage in manipulative conduct -with no intention of performing.
“[A] person’s ‘state of mind is, of course, a fact’ and thus may support a securities fraud claim.” Thompson ex rel. Thorp Family Charitable Remainder Unitrust,
Scrips’ promissory fraud claim fails for several reasons. Most fundamentally, because Scrips fails plausibly to allege that Ironridge engaged in any market manipulation, a fortiori it has not adequately pled that Ironridge’s purported promise that it would not engage in such manipulation was made with no -intention .to perform. Cf. Saberi v. Shell Oil Products,
Moreover, and relafedly, no facts are alleged that plausibly suggest Iron-ridge had no intention of performing at the time the alleged promise was made. Intent can be alleged generally. See Iqbal,
Because it alleges no such facts, Scrips’ complaint “does not ... explain how an inference that [Ironridge] intended to defraud [it] might be- drawn...
In sum, Scrips has fails to allege any misrepresentation, omission, or false promise adequately. Accordingly, its Rule 10b-5 claim fails to the extent based on misrepresentations, omissions, or false promises.
5. Whether Scrips Has Adequately Pled Reliance
Ironridge contends that Scrips has also failed to allege reliance sufficiently. Specifically, Ironridge argues that its ability to plead reliance is foreclosed by the stipulation’s , merger clause, that Scrips is not entitled to a presumption of reliance based on omissions or fraudulent statements, and that no presumption of reliance due to fraud on the market arises in this context or is adequately pled.
The court previously found that Scrips had failed to allege the reliance element of its Rule 10b-5 claim because it admitted in the stipulation on which the state court entered judgment that it had been “advised as to the terms and legal effect” of the stipulation, and the stipulation contained a merger clause stating that. Iron-ridge did not “make [and] ha[d] not made any representations or warranties other than those specifically set forth [therein].”
The merger clause in the stipulation forecloses any finding of reliance with respect to the misrepresentations, omissions, and false promise Scrips alleges. The fact that the stipulation states that Ironridge did not “make [and] ha[d] not made any representations or warranties other than those specifically set forth [in the stipulation]”
b. Reliance on Market Manipulation
In its prior order dismissing the first amended complaint, the court found unavailing Scrips’ assertion that it relied on the fact Ironridge was not manipulating the market in its stock. To plead the reliance element of a market manipulation claim adequately, plaintiff must allege that it relied on “an assumption of an efficient market free of manipulation.” See ATSI Communications,
Scrips alleges, as it did in the first amended complaint, that it entered into the agreement with Ironridge “in ignorance of the fact the price would be affected by- [Ironridge’s] manipulation.”
c. Presumptions of Reliance
Scrips attempts'to avoid the conclusion that it has failed to allege reliance adequately 'by asserting that it can invoke either of two presumptions of reliance. First, “a presumption [of reliance] is generally available to plaintiffs alleging violations of section 10(b) based on omissions of material fact.” Binder v. Gillespie,
Here, Scrips alleges multiple theories on which its Rule 10b-5 claim rests — it asserts that Ironridge made misrepresentations, that it failed to disclose material facts, that it was guilty of promissory fraud, and that it manipulated the market in Scrips’ stock.
- Scrips also contends that it is entitled to a presumption of reliance under the fraud-on-the-market theory. “The fraud-on-the-market presumption is based on the hypothesis that, in an open and developed securities market, the price of a company’s stock is determined by the available material information regarding the company and its business____ Misleading statements will therefore defraud purchasers of stock even if the purchasers do not directly rely on the misstatements[.]” Binder,
As the court noted in its order dismissing that first amended complaint, Scrips’ alleged misrepresentations were part of an arm’s length transaction; Scrips does not plausibly allege that the market incorporated the alleged misrepresentations.
The court noted these deficiencies in the first amended complaint; Scrips, however, failed to include allegations in the second amended complaint that suggest Ironridge made material public statements that were false or that it did not publicly disclose material information. Consequently, Scrips cannot invoke the fraud-on-the-market presumption of reliance to support its manipulation claim.
Even were this not true, moreover, Scrips cannot invoke the fraud-on-the-market presumption of reliance because its shares trade on the OTC market; although it has added allegations that the market in its stock is efficient, those allegations fail to plead the fact plausibly. “[T]o invoke the fraud-on-the-market presumption ... the plaintiff must (1) show that the security in question was traded in an efficient market (a fact conceded here), and (2) show that the alleged misrepresentations were public.” See Connecticut Ret. Plans & Trust Funds v. Amgen Inc.,
“The fraud-on-the-market presumption is only available when the plaintiff demonstrates that the security which the defendant’s allegedly fraudulent behavior concerned was actively traded in an efficient market.” See Huberman v. Tag-It Pac. Inc.,
Scrips counters that, despite the lack of authority finding the OTC market efficient, it has adequately pled that an efficient market in its stock exists. Courts typically apply the five factors set forth in Cammer v. Bloom,
(1) Volume
The Cammer court identified a large weekly trading volume as one factor indicative of market efficiency because “the existence of an actively traded market, as evidenced by a large weekly volume of stock trades, .. implies a likelihood that many investors are executing trades on the basis of newly available or disseminated corporate information.” Cammer,
Scrips’ only allegation regarding this factor is that “the weekly trading volume in Scrips’ stock is large enough to at least establish a substantial presumption of efficiency (at well over 1% of the total amount of shares).” It supports the allegation with the trading data it has attached to the second amended complaint.
Although Ironridge does not' ask the court to do so, the court sua sponte takes judicial notice of the volume of Scrips’ shares traded from December 1, 2013 to April 28, 2014. See Loveman v. Lauder,
Because Scrips’ allegation concerning trading volume, is not' ’plausible, and because it is contradicted by information that is properly the subject of judicial notice, the court concludes that this factor weighs against a finding that there was an efficient market in its stock.
(2) Analyst Reporting
As Cammer noted, “it [is] persuásive to allege a significant number of securities analysts followed and reported on a company’s stock during the [relevant] period ... [because] [t]he existence of such analysts would imply ... reports were closely reviewed by investment professionals, who would in turn make buy/sell recommendations to client investors.” Cammer,
(3) Market Makers and Arbitrageurs
Market makers and arbitrageurs “ensure completion, of the market mechar nism; these individuals ... react swiftly to company news and reported financial results by buying or selling stock and driving it to a changed price level.” Cammer,
Scrips alleges that its stock had “numerous market makers and arbitrageurs, including Knight Capital Americas LLC, Stockcross Financial Services, Inc, BMA Securities, Cantor Fitzgerald & Co., BNY Mellon Capital. Markets, LLC, Biltmore International Corp., Wilson-Davis & Co., Inc., Vfinance Investments, Inc. and Guggenheim Investor Services, LLC.”
(4) SEC Form S-3
The fourth Cammer factor examines “whether the company is eligible to file SEC registration form S-3, as opposed to form S-1 or S-2.” Binder,
Scrips has not alleged that it files or is eligible to file an SEC Registration Form S-3. Ironridge argues that Scrips does not satisfy the requirements of 17 C.F.R. § 239.13, and thus in fact files Form S-1.
Scrips does not demonstrate that it is eligible to file a Form S-3 or that its ineligibility is due to timing. Thus, the court finds Scrips’ ineligibility to file an SEC Registration Form S-3 weighs against a finding that there is an efficient market in its stock. See Turbodyne Technologies,
(5) Causal Nexus
The last factor identified in Cammer takes into account the fact that “a cause and effect relationship between unexpected corporate events or financial releases and an immediate response in the stock price ... is the essence of an efficient market and the foundation for the fraud on the market theory.” Cammer,
Ironridge contends that Scrips has not only “cherry pick[ed]” the dates it cites to show a causal link between press releases and stock price, but also fails to allege that the press releases caused the price movement.
Ironridge also asserts that the exhibits to Scrips’ second amended complaint belie any purported causal link between press releases and stock price. It contends data set forth in Exhibit 4 indicates that Scrips’ stock price fluctuated significantly on many days.
Scrips also alleges that it stock price climbed from $0.12 to $0.14 on December 19, 2013 because of a positive orders report. Once again, however, Exhibit 4 reflects that Scrips’ stock opened that day at $0.13, only one cent less than its price, at the close. What Scrips does not explain is why one week earlier, its stock was trading at $0.15 or more.
More - fundamentally, Scrips does not suggest that there is any causal nexus that accounts for multiple sharp drops in its share price.- Ironridge notes that on August 12, 2013 Scrips shares fell from $0.35 to $0.28; on August 14, 2013, after rebounding from the earlier fluctuation, the shares again fell from $0.38 to $0.31; • on September 12, 2013, the - stock dropped from $0.23 to $0.14; and on October 23, 2013, it fell from $0.33 to $0.25 cents.
Considering the second amended complaint as a whole — both Scrips’ allegations and the trading data-in the exhibits attached to the complaint, the court eon-cludes'>that Scrips has'failed' adequately to allege a coherent cause-and-effect relation
d. Conclusion Concerning Reliance
Because Scrips fails to allege facts that give -rise to a plausible inference Of actual reliance, and because it cannot invoke either of the available presumptions of reliance, the court would have to dismiss its Rule 10b-5 claim even had it adequately alleged misrepresentations, omissions, false promises, or manipulative conduct.
6. Whether Scrips Pleads Particularized Facts Giving Rise to a Strong Inference, of Scienter
Ironridge next contends that Scrips’ scienter allegations are inadequate; it notes, in this regard, that the court has twice held that. Ironridge’s disclosures were inconsistent with an. intent to deceive,
Scrips cites several factors that-it argues give rise to a strong inference of scienter: (1) Ironridge’s allegedly manipulative trading activity; (2) the adjustment mechanism in the agreement; (3) Ironridge’s alleged misrepresentations; and (4) -Ironridge’s alleged pattern of fraud.
a. Manipulative Trading Activity
Scrips argues first that Ironridge’s manipulative trades evidence scienter. The court has concluded, however, that Scrips failed adequately to allege manipulative trading. Even had it done so,- morepver, its scienter allegations would fail. In its prior order, the court noted that “the features of open-market transactions ... that give rise to an inference of manipulative intent [and noted that they include] for example, [the] timing, size, or repetition of a transaction.” S.E.C. v. Masri,
b. Adjustment Mechanism
Scrips argues that the adjustment mechanism “creates a powerful, extra incentive for the manipulative conduct.”
c. Ironridge’s False Promises and Failure to Disclose
Scrips argues ■ Ironridge “never told [Scrips] that it was. going to exploit its rights under the agreement to put downward pressure on the share price,” and “never disclosed an intent to subsequently use the issued shares to manipulate the market.”
The court also finds unavailing Scrips’ second argument — that Ironridge engaged in bait-and-switeh tactics by proposing one adjustment mechanism initially and substituting another during final negotiations shows “consciousness of something wrongful to hide or at l[e]ast obfuscate.”
d. Pattern of Fraud
The court previously concluded that the original complaint failed to plead facts giving rise to a strong and compelling inference of scienter. It noted that, although the complaint was replete with allegations of a “scheme to defraud and manipulate,” they were conelusory and failed to raise the claim above the speculative level; as a consequence, it found they did not support a cogent and compelling inference of scienter. See Twombly,
“The scienter behind [Ironridge’s] conduct is shown by, among other things, the fact that the conduct was part of a much wider pattern of illegal and deceptive activity. Indeed, [Ironridge] has engaged in essentially the same or similar wrongful conduct in connection with the stock of many other companies. The watchdog website ‘Scam Informer’ recently observed that ‘[t]he destruction in stocks [IRONRIDGE] has completed transactions with makes the devastation from Hurricane Irene seem tame by comparison.’ While the Plaintiff is not yet in a position to allege the depredations that IRONRIDGE has wrought with the stock of other companies with the same degree of particularity that it has been able to muster for its own stock, the fact that there are widespread reports of such conduct should play some role — at least at the pleading stage — in bolstering the inference of scienter. For example, Streetlnsider.eo, has reported that NewLead Holdings initiated an arbitration against IRON-RIDGE in the same time frame as this suit, with nearly the same causes of action asserted here, including allegations of share price manipulation under the same kind of funding vehicle. It has been reported that Ironridge has already requested and/or received an aggregate of approximately 62 million common shares (through July 6, 2014) and received approximately $22.8 million of proceeds (based upon information received from Ironridge) on the sale, in NewLead Holdings’ belief, of approximately 44 million of common shares through June 30, 2014.”160 '
Courts typically treat anonymous internet postings as tantamount to confidential witness statements. See In re Apollo Group, Inc. Securities Litigation, No. CV 10 1735 PHX JAT,
A complaint relying on the statements of confidential witnesses to establish scienter (1) must describe the confidential witnesses with sufficient particularity to establish their reliability and knowledge, and (2) must plead statements by confidential witnesses with sufficient reliability and personal knowledge that are indicative of scienter. See Zucco Partners,
Scrips also alleges that Sims — who purportedly makes all decisions for Iron-ridge — “has been implicated in a variety of schemes involving fraud and market manipulation related to at least 32 publicly traded companies, all [of which] reveal[ ] a similar scheme' involving convertible instruments and/or the issuance of shares based upon the trading price of the respective issuer’s common shares and subsequent manipulation of the issuer’s stock price for the purpose of receiving additional shares.”
Finally, Scrips alleges that other companies have been harmed by Ironridge, and have filed claims against it:
“Among the companies that have been victims of IRONRIDGE’s schemes is Green Automotive Company, Inc., which is the subject of-a similar stipulation/order in a Los Angeles Superior Court action, under the Section 3(a)(10) exemption. Incredibly, IRONRIDGE actually seeks 6 billion shares in Green Automotive, which is six times the com-panjfs total capitalization. That is a vivid illustration of the absurdly deceptive, abusive and bad faith manner in which IRONRIDGE has been obtaining and implementing the type of stipulation/order at ■ issue here. In fact, as noted above, the court declined to enforce the same stipulation language at issue here against Green Automotive. As another, even more vivid example of IRONRIGE’s predatory conduct, IR-ONRIDGE has recently asserted that it is entitled to 27 billion shares of another company, Green Innovations, Ltd. Plaintiffs counsel, who also represents Green Innovations, can aver that the leadership of that company believes that IR-ONRIDGE has wronged it in the very same way that IRONRIDGE has wronged the Plaintiff in this action.”
Scrips also asks that the court take judicial notice of an SEC “Order Instituting Administrative and Cease-and-Desist Proceedings Pursuant to Sections 15(b) and 21(c) of the Securities Exchange Act of 1934.”
At the hearing, Scrips argued that the court should give greater weight to the SEC order because it was' issued by a government agency rather than a private party. There is no authority suggesting that the allegations in an SEC order, which are unproved and contested, can properly be considered evidence of scieri-ter. More fundamentally, the SEC order does not allege manipulative or fraudulent conduct. It charges alleged violations of § 15(a) of the Securities, Exchange Act of 1934,
In short, there are no particularized allegations demonstrating a pattern of fraud. Thus, Scrips’ “pattern of fraud” argument
e. Holistic Review
Even in combination, the facts Scrips pleads regarding scienter do not support a strong inference of scienter. Given the disclosures in the stipulation, and the lack of particularized allegations concerning Ir-onridge’s purported pattern of fraud and purportedly manipulative trades, the more compelling inference is that Ironridge did not intend to deceive, and that Scrips knew — or should have known — the nature of the transaction into which it had entered. Holistic review therefore does not demonstrate that it has sufficiently pled scienter. See In re Verifone Holdings, Inc. Securities Litigation, No. CV 07-06140 MHP,
D. Whether the Rule 10b-5 Claim Should Be Dismissed With Prejudice
Ironridge contends that the court should dismiss Scrips’ Rule 10b-5 claim with prejudice, and decline to exercise supplemental jurisdiction oter the state law claims currently stayed under the Colorado River doctrine. It cites a number of Ninth Circuit cases affirming dismissals without leave to amend where the “plaintiff [was] previously ... granted leave to amend and ... failed to add the requisite particularity to its claims.”. See, e.g., Zucco Partners,
Scrips has now had three opportunities to plead viable claims. Despite being informed of its obligation to supply particularized allegations supporting a Rule 10b-5 claim, Scrips merely appended 200 pages of raw trading data to the complaint, leaving the court (and Ironridge) to sift through the data to ascertain which trades were purportedly manipulative and why they were so. The court’s review of the data indicates that Ironridge’s trades were not manipulative in the manner Scrips suggests. In its opposition, Scrips argued that “a greater level of particularity in the allegations regarding the transactions at issue” could not be imagined, given the “highly granular transactional details ... [set forth in the] voluminous set of data analysis that was prepared by an expert.”
Ironridge countered that Scrips made the very same argument, i.e., that it would
Ironridge also aptly noted that even were Scrips to cure its allegations of market manipulation generally, it has . still failed to allege reliance or seientey. Scrips, in fact, did not address reliance at the hearing, and relied in its most recent complaint on the same inferences of scien-ter the court previously found insufficient. Its only reference to scienter at the hearing involved a mischaracterization of the unproved facts alleged by the SEC. This does not suffice to plead scienter under Rule 10b-5. In dismissing the first amended complaint, the court warned Scrips that if it failed to address the deficiencies noted in prior complaints, it would likely , conclude that further amendment was futile and dismiss the complaint with prejudice. Given the content of the second amended complaint, and the absence of any specific facts cited by Scrips that would cure the numerous deficiencies noted in this order, the court concludes that granting leave to amend would be futile, and dismisses Scrips’ Rule 10b-5 claim with prejudice. See California ex rel. California Department of Toxic Substances Control v. Neville Chemical Co.,
E. Whether the Court Should Exercise Supplemental Jurisdiction Over Scrips’ State Law Claims
Ironridge' argues that the court should decline to exercise supplemental jurisdiction over Scrips’ remaining state law claims, citing Carnegie-Mellon University v. Cohill, 484 U.S.- 343,
III. CONCLUSION
For the reasons stated, the court grants Ironridge’s motion to dismiss Scrips’ Rule 10b-5 claim with prejudice. The court declines to exercise supplemental jurisdiction oyer Scrips’ state law. claims. The second amended complaint is therefore dismissed in its entirety.
. Id., 1111.
. Hooker v. Fidelity Trust Co.,
. Motion to Dismiss or Stay Plaintiff’s Complaint, Docket No. 9 (Jun. 25, 2014).
, Order Granting in Part and Denying in Part Motion to Dismiss and Granting Motion to Stay ("Order"), Docket No. 18 (Nov. 3, 2014).
. First Amended Complaint ("FAC”), Docket No. 19 (Dec. 3, 2014).
. Motion to Dismiss First Amended Complaint, Docket No. 20 (Dec. 17, 2014). See also Reply in Support of Motion to Dismiss, Docket No. 26 (Mar. 16, 2015).
. Opposition to Motion to Dismiss, Docket No. 25 (Mar. 9, 2015).
. Dismissal at 1.
. Second Amended Complaint ("SAC”), Docket No. 30 (Apr. 27, 2015).
. Motion to Dismiss Second Amended Complaint and Memorandum of Points and Authorities in Support thereof (“Motion”), Docket No. 32 (May 27, 2015).
. Opposition to Motion to Dismiss Second Amended Complaint ("Opposition”), Docket No. 36 (June 25, 2015); Reply in Support of Motion to Dismiss (“Reply”); Docket No. 37 (July 10, 2015).
. - SAC, ¶4, 11.
. Id.
. Id.
. Id.
. Id., ¶ 12.
.. Id.
. Id., ¶ 13. See also id., Exh. 1 (Term Sheet).
. Id., ¶ 12.
. Id., ¶ 15.
. Id.
. Id.
. California Corporation Code § 25017(f)(3) excludes from the definition of offer or sale— and hence from the ambit of California’s securities registration laws — "any act incident to a transaction or reorganization approved by a state or federal court in which securities are issued and exchanged for one or more outstanding securities, claims, or property interests, or partly in that exchange and partly for cash.” See Cal. Corp. Code § 25017(f)(3). Section 3(a)(10) of the Securities Act of 1933 exempts from registration "any security which is issued in exchange for one or more bona fide outstanding securities, claims or property interests ... where the terms and conditions of such issuance and exchange are approved, after a hearing upon the fairness of such terms and conditions at which all persons to whom it is proposed to issue securities in such exchange shall have the right to appear, by any court, or by any official or agency of the United States, or by any State or Territorial banking or insurance commission or other governmental authority expressly authorized by law to grant such approval.” See 15U.S.C. § 77c(10).
. Declaration of Shannon E. Mader in Support of Defendants' Motion to Dismiss (“Mader Decl.”), Docket No. 32-1 (May 27, 2015), Exh. A (Ironridge’s State Court Complaint for Breach of Contract Against Scrips) ("State Court Complaint”), ¶¶ 1-6.
. See SAC, ¶ 16. See also id., Exh. 3 (Stipulation for Settlement of Claims) ("Stipulation”), ¶¶ 1-3.
. See Stipulation, ¶¶ 1-3.
. Id., ¶ 6.
. Id.
. Id., ill.
. Id., ¶ 6.
. Id., "hi.
. Id.
. Id., ¶ 8.
. Id., ¶10.
. Id., ¶ 9.
. Mader Decl., Exh. C (Joint Ex Parte Application for Order Approving Stipulation for Settlement of Claims) at 2-3.
. Id.
. Brandon O’Neil, Ironridge’s Managing Director, stated that the terms of the agreement were fair to Ironridge. (See Mader Decl., Exh. D (Declaration of Brandon O’Neil in Support of Joint Ex Parte Application for Or
.Stipulation, ¶ 4 (“Plaintiff has agreed to the proposed terms and conditions, and believes that they are sufficiently fair such that [Ironridge] is willing to enter into this stipulation. [Scrips’] board of directors has considered the proposed transaction and has resolved that its terms and conditions are fair to, and in-the best interest of, [Scrips] and its stock holders. Accordingly, both parties request Court approval of the settlement provided for herein as fair, just and reasonable”).
. Id., Exh. F (Order for Approval of Stipulation for Settlement .of Claims).
. SAC, ¶ 21.'
. Id.
. Id., ¶ 22.
. Id., ¶ 31.
. Id., ¶ 25.
. Id.A 22.
. Id.
. Id., ¶ 24.
. Id., ¶¶28, 32.
. Id., ¶ 29; see also id., Exh. 5.
. Id., ¶ 30.
. Id., ¶ 31. Scrips asserts that its stock rose following information released on October 21, 2013 (from nineteen cents to twenty-six cents in response to a press release regarding its acquisition of PIMD International, LLC); on October 28, 2013 (from twenty-three cents to twenty-eight cents in response to a press release regarding negotiations to launch drug distribution in the Chinese OTC market); on October 30, 2013 (from twenty-eight to thirty cents in response to a press release regarding PIMD’s new medical supply product website); on November "11, 2013 (from nineteen cents to twenty-three cents in response to a press release regarding WholesaleRx's investment in Scrips); on November 25, 2013 (from sixteen cents to eighteen cents in response to a press release regarding business development in China); on December 19, 2013 (from twelve cents to fourteen cents in response to a press release that Scrips processed record high orders); on January 31, 2014 (from nineteen cents to twenty cents in response to a press release regarding Scrips new management agreement with a New Jersey compounding pharmacy); on February 10, 2014 (from thirteen cents to fourteen cents in response to a press release regarding Scrips’ registration approval for pain reliever from the government of Hong Kong); on February 12, 2014 (from fourteen to .sixteen cents in response to a press, release regarding Wholesale Rx); on February 18, 2014 (from twelve cents to thirteen cents in response to a press release regarding the start of Scrips’ prepayment of convertible debt); on March 5, 2014 (from ten cents to eleven cents in response to a press release concerning prescription sales by a specialty pharmacy with which Scrips had a management agreement); and on June 2, 2014 (from eleven cents to twelve cents in response to a press release regarding the same specialty pharmacy and the fact that it had $1.6 million in sales for the month of May). It also asserts that on February 3, 2014, its stock went from twenty cents to nineteen cents in response to a press release regarding Scrips’ joint venture with Global Pharma Hub. (Id.)
. Id., ¶ 38.
. Id., ¶ 39.
. id.A 40.
. Id.
. Id., ¶ 41.
. Id., ¶¶ 42-44.
. See Mader Deck, Exh. G (Plaintiffs Ex Parte Motion for an Order Compelling Issuance of Shares) ("Order to Compel”).
. Id., .Exh, H (Defendant’s Opposition to Plaintiff's Ex Parte Motion for an Order Compelling Issuance of Shares) (“Order to Compel Opp.”).
. Id. at Í.
. Id. at 3.
. Id. at 4-5.
. Id. at 4.
. Mader Deck, Exh. I (Order Enforcing Pri- or Order for Approval of Stipulation for Settlement of Claims) (“Enforcement Order”) at 1-2.
. Id., Exh. J (Notice of Appeal).
. As noted, the court's November 3, 2014 order dismissed Scrips’ declaratory relief claim under Rooker-Feldman to the extent it sought a declaration that Scrips was excused from performing under the stipulation.
. Id., ¶ 26.
. Id., ¶ 33. It is unclear from the complaint and judicially noticeable documents why Scrips asserts, on the one hand, that it has already issued 10.3 million shares to Iron-ridge (i.e., the approximately 8.7 million shares initially issued plus the additional 1,6 million that are the subject of the enforcement order), and on the other, that Ironridge seeks "a further 1.6 million shares through the California courts.” (Id., ¶ 34.) The complaint does not allege that Scrips has issued any stock to Ironridge beyond the initial 8.69 million shares.
. Id., ¶ 34.
. Id., ¶ 36.
. "Under the disentitlement doctrine, a reviewing court has inherent power to dismiss ' an appeal when the appealing party has refused to. comply with the orders of the trial court. Appellate disentitlement is not a jurisdictional doctrine, but a discretionary tool that may be applied when the balancé of the equitable concerns makes- it- a proper sanction. The rule applies even if there is no formal adjudication of co.ntempt[, and] is particularly likely to be invoked where the appeal arises out of the very order (or orders) the party has disobeyed.” Ironridge Global IV, Ltd.,
. Request for Judicial Notice (“RJN”), Docket No. 33 (May 27, 2015) at 2-3.
. Taking judicial notice of matters of public record does not convert a motion to dismiss into a motion for summary judgment. MGIC Indemnity Corp. v. Weisman,
. RJN at 2-3. See also Mader Dec!,, Exhs. V-EE.
. Id.
. "The court takes judicial notice of the SEC filings only for their existence and contents, not for the truth of the information contained in them.” See Ixia,
. Opposition, Declaration of Carlos Need-ham, Exh. A (“SEC Order”).
. The PSLRA creates a "safe harbor” for "forward-looking" statements that are immaterial, are limited by "meaningful cautionary statements,” or are made without actual knowledge of their falsity. 15 U.S.C. §§ 77z-2(c), 78u-5(c), Such statements include, but are not limited to, statements of future economic performance and management plans and objectives. 15 U.S.C. §§ 77z-2(I), 78u-5(1). This "safe harbor” has much the same effect as the "bespeaks caution” doctrine, which provides that forward-looking representations that contain adequate cautioqary language or risk disclosure protect a defendant from securities liability. See, e.g., Plevy v. Haggerty,
. Order at 21.
. SAC, ¶ 53(a)-(c) (listing transfers to brokerage accounts in Ironridge’s name at U.S. Bank Corp. and Albert Fried & Company, LLC, and in the name of Caledonian Bank Limited at Scottsdale Securities).
. Id., ¶ 59.
. Order at 22.
. Mader Dec!., Exh. M (November 8, 2013 Section 13(d) Disclosure) at 11.
.Id. at 11 (stating that Ironridge is "prohibited from ... voting any shares of issuer’s common stock owned or controlled by them’’); Stipulation, ¶ 12 ("neither [Iron-ridge] nor any of its affiliates shall: (a) vote any shares of Common Stock owned or controlled by it”).
. Motion at 12.
. SAC, ¶ 22.
. At the hearing, Scrips stressed that courts have applied a lower pleading standard to stock manipulation claims. Given that the court applies the lower standard here, and that it did so in its prior order dismissing the first amended complaint, this argument does not affect the outcome.
. Order at 24.
. Id., V 22-24. .
. Id.; see id., Exh. 5.
. id., ¶ 23.
. Opposition at 1.
. Reply at 1.
. SAC, Exh. 5 at 60-61.
. Id. at 71.
. Id. at 286-87.
. Id. at 87-88.
. Id. at 88.
. Id. at 99-100.
. Id. at 104-05.
. Id. at 63.
. Id. at 66-68.
. Id. at 70-71.
. Id.
. Id. at 72-75.
. Id. at 77-79.
. Id. at 91-95.
. Id. at 3; 11 n. 4.
. Opposition at 1.
. Scrips no longer alleges, as it did in the first amended complaint, that Irongate did not disclose Sims’ involvement in the transaction. There, Scrips alleges that it “did not learn of Sims’ involvement until after transaction documents were executed and it received its funding from [Ironridge].” It asserted that as a result “of the astounding number of lawsuits involving Sims and companies under his control, [Ironridge] knew that [Scrips] would reject its financing if Sims’ interest and the actions against his related entities were disclosed.” (FAC, ¶ 42.) Ironridge’s omission, Scrips argued, “was akin to failing to disclose that one is actually going into business with Bernie Madoff.” (Id.) By omitting these allegations, Scrips has abandoned reliance on this theory. The allegations fail to state an actionable omission in any event. As the court explained in its prior order, Scrips knew that Sims was involved in the transaction because the initial term sheet ironridge gave Scrips was signed by Sims as Ironridge’s director; so too was the state court stipulation. Ironridge. had also filed 62 Schedules 13G with the SEC prior to execution of the stipulation; each listed Sims as an Ironridge director. Thus, Scrips’ allegation that it did not leam of Sims’ involvement until after the transaction documents were executed and it had received funding from Ironridge was contradicted by documentó incorporated by reference in the complaint. See Sprewell,
.SAC, ¶ 18.
. The filing included a declaration by O'Neil that explained the operation of the adjustment mechanism. (O'Neil' Decl., ¶ 5 ("Based on my analysis, the terms and conditions of the issuance and exchange are fair to Ironridge. The number of shares to be issued pursuant to the settlement should more than fairly compensate Ironridge for the claims. The market value of the shares to be issued, based on the public sale prices of the Company’s stock on its trading market, should ultimately represent a premium to the dollar amount of the claims. The Stipulation provides for an adjustment mechanism, based on the average of the five lowest daily volume weighted average prices during a defined calculation period, such that the aggregate number of shares issued to Ironridge should represent a premium to the average price of the Company’s stock over such time. This adjustment mechanism, combined with Ironridge’s ability to sell shares at any time, including during the calculation period, provide a substantial measure of protection to Ironridge for price fluctuations in the Company’s stock. Such fluctuations are likely given the Company’s trading history and the terms of the Stipulation”).)
. Schneiderman Deck, ¶ 8
. Mader Deck, Exh. L (November 7, 2013 Form 8-K) at 3 ("On November 18, 2013 the Registrant's transfer agent delivered to Iron-ridge 8,690,000 shares of the Registrant’s common stock. The shares issued to Iron-ridge are freely tradable and exempt from registration under the Securities Act of 1933, as amended (the 'Securities Act’) pursuant to Section 3(a)(10) of the Securities Act and Section 25017(f)(3) of the California Corporations Code. The number of shares issued to Iron-ridge is subject to adjustment based on the trading price of the Registrant’s stock such that the value of the shares is sufficient to cover the Claim Amount, a 10% agent fee amount and Ironridge’s reasonable legal fees and expenses ( the ‘Final Amount’). Under the Stipulation Order, Ironridge may not be the beneficial owner of more than 9.99% of the Registrant’s outstanding shares of common stock until the Final Amount is paid. Further Ironridge has agreed not to exercise any voting rights of the shares issued to it nor influence or cause any change in control of the Registrant”).
. See generally Motion to Compel Opp.
. SAC, ¶ 53(a)-(c).
. Id., ¶ 12.
. Motion at 16.
. Stipulation, ¶¶ 11, 16.
. Bank of the West involved common law fraud, but the Ninth Circuit has applied its reasoning to Rule 10b-5 claims. See Paracor Fin., Inc.,
. Stipulation, ¶¶ 11, 16.
. Id.
. SAC, ¶ 26.
. See, e.g., SAC, ¶ 68 (“The Defendants each employed devices, schemes and artifices to defraud and to manipulate Plaintiff's stock price, made untrue statements of material fact, and omitted to state material facts necessary to make their statements not misleading, and engaged in acts, practices and a course of business that operated as a fraud and deceit upon the Plaintiff').
. Order at 36.
. SAC, ¶ 72.
. Scrips argues it has adequately alleged the existence of an efficient market under Cammer, but also suggests that the market efficiency of a particular stock is a question of fact inappropriate for resolution in the context of a motion to dismiss. (Opposition at 12-13.) There is some authority that supports this position. See, e.g., Salvani,
. SAC, ¶ 29; id., Exh. 5.
. Mader Decl., Exh. Y at 1.
. SAC, ¶ 30.
. Motion at 20 n. 9.
. Motion at 19.
. Id.; Reply at 8.
. SAC, ¶ 31.
. Reply at 7.
. Motion at 18.
. Mader Decl., Exh. V (Form 10-Q) at 23.
. Id. at 10-11.
. Id. Exhs. W and X (Forms 10-Q).
. Motion at 18-19.
. SAC, Exh. 4 at 6-8.
. Id.
. Motion at 20.
. SAC, ¶ 38.
.Order at 45.
. Order at 43.
. SAC, ¶ 38.
. Motion at 21.
. SAC, ¶ 38.
. Id.
. Order at 46 (quoting Stipulation, ¶¶ 6, 11).
. O’Neil Decl., ¶ 5.
. Stipulation, ¶¶ 11, 16.
.Order at 46.
. SAC, ¶ 38.
. Stipulation, ¶¶ 11, 16.
.Schneiderman Decl., ¶ 8.
. SAC, ¶ 38.
. Id., ¶ 35.
. Opposition at 4;= see also zd. Declaration of Carlos Needham ("Needham Decl.”), Exh. A ("SEC Order”) at 1.
.Opposition at 14-15.
.Section 15(a) of the Securities Exchange Act of 1934 provides:
"It shall be unlawful for any broker or dealer which is either a person other than a natural person or a natural person not associated with a broker or dealer which is a person other than a natural person (other than such a broker or dealer whose business is exclusively intrastate and who does not make use of any facility of a national securities exchange) to make use of the mails or any means or instrumentality of interstate commerce to effect any transaction in, or to induce or attempt to induce the purchase or sale of, any security (other than an exempted security or commercial paper, banker’s acceptances, or commercial bills) unless such broker or dealer is registered in accordance with subjection (b) of this section.” -15 U.S.C. 780(a).
"The term ‘broker’ means any person engaged in the business of effecting transactions in securities for the account of others, but does not include a bank.” 15 U.S.C. 78c(4).
. SEC Order, ¶ 1. .
. M, ¶¶ 20-23.
. Opposition at 1.
